Background and Objectives: The DNA probe assay is an alternative to culture for the detection of Neisseria gonorrhoeae which does not depend on the viability of the organism. There have been few published studies comparing the two methodologies. The majority of these studies have shown the probe assay to be comparable to culture. The goal of this study was to compare the performance of the DNA probe assay with culture in a high prevalence setting with nearly optimal culture transport conditions. Methods: Genital specimens for culture and for DNA probe assay were collected at the time of the routine visit for STD clinic patients. 
Introduction
Currently, with the exception of Gram stain, the only available testing method alternative to culture for the detection of Neisseria gonorrhoeae is the unamplified DNA probe (GenProbe PACE 2, Gen-Probe Inc, San Diego, CA). The potential advantage of the probe assay over culture is its ability to detect nonviable as well as viable organisms. The relative fastidious nature of the gonococcus may lead to loss of viability, and therefore false negative cultures, in instances where cultures are not properly incubated or must be shipped long distances to the laboratory.' 4 The growth of N gonorrhoeae may also be affected by recent use of antibiotics by patients, a common phenomenon among patients attending sexually transmitted disease (STD) clinics. 5 Finally, DNA probe testing more easily lends itself to semi-automation and thus may result in cost-savings for personnel. These perceived advantages have led some STD control programmes to substitute this methodology for culture for the detection of gonorrhoea, despite the fact that there have been relatively few published studies of the performance of the assay.'" Prior to serious consideration of implementing the DNA probe as the primary testing modality for gonorrhoea in its STD clinics, the Chicago Department of Health compared the assay with culture in a setting where transport conditions to the central laboratory were adequate.
Methods

Study population
The study was conducted at each of the five Chicago Department of Health clinics scattered throughout the city which specialised in the diagnosis and treatment of STDs. During the month of January, 1994, all patients seen for a new problem were screened for gonorrhoea with both culture and DNA probe assays. The usual prevalence of gonorrhoea in this population as determined by the clinic's activity reports was estimated to be 10% for women and 21 % for men.
Specimen collection Endocervical specimens were obtained by inserting an unlubricated speculum into the vagina and exposing the cervix. Following cleaning of the ectocervix with a large swab, a cotton-tipped swab was inserted into the os and gently rotated. The specimen was first placed onto a clean glass slide for Gram's stain and then inoculated onto a modified ThayerMartin agar plate at the bedside. Urethral specimens were obtained by inserting a small diameter calcium alginate swab 2-3 cm into the urethra. Following gentle rotation, the swab was withdrawn and a slide and agar plate prepared as above. Specimens for DNA probe testing were collected following the specimens for culture in the same manner, using the swab provided in the test kits. specimens but subsequently concluded the assay was as sensitive as culture when a modification of the manufacturer's cut-off value was utilised. The only published study which has compared probe with culture under conditions that included long distance transport, utilised specimens obtained from family planning clinics that had a 1 % prevalence of gonorrhoea. This study also altered the manufacturer's cutoff value by classifyfing those specimens with RLUs in the "grey-zone" (300-500) as suspicious. When suspicious specimens were included as positives, the sensitivity and specificity in this low prevalence population were both 98%; however, the positive predictive value of the probe assay was only 37-6%.9 Our findings differ from those of previously reported studies, with the exception of Panke et al, in that we found the overall sensitivity of the probe assay to be less than 90%. In women, the sensitivity fell to 86%. Use of the direct patient Gram stain to resolve discrepant results failed to significantly improve the sensitivity, although we acknowledge that endocer- Of concern also is the relatively poor specificity of the DNA probe assay in this study. After 
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